NEW YORK, March 5 - Orchid BioSciences and First Genetic Trust on Tuesday said they plan to co-develop and market a range of pharmacogenetic services to the private sector, academia, and health-care providers.

The alliance hopes to provide researchers the tools to asses the correlates between genotypes and phenotypes. Specifically, it seeks to generate patient registries and support clinical trials, develop and validate assays, and provide genotyping services, bioinformatics, and data management.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.